SS-31: Mitochondrial Research Overview

Introduction

SS-31 belongs to the Szeto-Schiller (SS) family of peptides, developed by Hazel Szeto and Peter Schiller. Its alternating aromatic–cationic design allows it to cross cell membranes and accumulate at the inner mitochondrial membrane, making it a useful probe of mitochondrial biology.

What Is SS-31?

SS-31 is the tetrapeptide D-Arg-2′,6′-dimethyl-Tyr-Lys-Phe-NH₂. The D-arginine and dimethyltyrosine improve enzymatic stability. It carries a net +3 charge at physiological pH. In clinical development it has been referred to as elamipretide.

Why Is It Studied?

Cardiolipin is a phospholipid found almost exclusively in the inner mitochondrial membrane, where it supports the organization of electron-transport complexes and cristae structure. SS-31 is studied because it associates with cardiolipin, offering a way to investigate how cardiolipin integrity relates to bioenergetic function.

Research Background

Early work in the 2000s showed SS peptides concentrating in mitochondria of cultured cells and reducing markers of oxidative damage in isolated mitochondria. Later studies proposed cardiolipin binding as the primary interaction. Clinical programs have evaluated elamipretide in several conditions involving mitochondrial dysfunction; results have been mixed and are specific to the studied populations and formulation.

Evidence classification: mechanism is from biophysical, isolated-mitochondria, cell and animal studies. Controlled human trials of elamipretide exist but are condition-specific, and outcomes have been inconsistent across trials.

Mechanism and Scientific Principles

• Electrostatic and hydrophobic association with cardiolipin (biophysical / in vitro).
• Reported effects on cytochrome c peroxidase activity and electron transfer (in vitro).
• Preservation of cristae morphology in stressed mitochondria (in vitro / animal).

Compare this membrane-targeting approach with a mitochondria-encoded signaling peptide in MOTS-c: Mitochondrial Research Explained.

Analytical and Experimental Considerations

• Confirm the non-standard residues (D-Arg, Dmt) and C-terminal amide by mass spectrometry.
• Chiral purity matters for D-amino-acid peptides and may require specialized methods beyond standard HPLC.
• As a small, highly charged peptide, counter-ion content can be substantial — see Peptide Purity vs Quantity.

Limitations of Current Research

Mechanistic debate continues about the precise molecular interactions. Clinical results do not uniformly confirm preclinical findings, underscoring why preclinical data should not be extrapolated.

Frequently Asked Questions

Scientific References

1. Zhao K, Zhao GM, Wu D, et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem. 2004;279(33):34682-34690. [In vitro / animal] View source (opens in new tab)
2. Birk AV, Liu S, Soong Y, et al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. J Am Soc Nephrol. 2013;24(8):1250-1261. [In vitro / animal] View source (opens in new tab)
3. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171(8):2029-2050. [Review] View source (opens in new tab)